Nick Bruce has joined MAP Biopharma after a long and distinguished career in the NHS, consultancy and the pharmaceutical industry. In the new post he will oversee MAP's general market access consulting offering and will work closely with the health economics & outcomes research team led by Jade Marshall. Bruce is a former NHS economist who worked for Health Authorities in South West London and at a health economics consultancy. He joined the pharmaceutical firm Pfizer in 1998 to set up its market access team and has held roles of increasing seniority responsible for market access, health policy, government affairs and media communications. He is a former ABPI representative on the Scottish Medicines Consortium appraisal committee and a former member of the ABPI Board of Management.